Health Trials

Cradiovascular-kidney-liver-metabolic (CKLM) Syndrome

1

Review clinical trials related to Cradiovascular-kidney-liver-metabolic (CKLM) Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry

The aim of this clinical and exploratory Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry is to establish high quality prevalence and incidence database for Cardiovascular-Kidney-Metabolic (CKM) syndrome, its major contributors, and the extent of the respective organ damaged.

Participants needed: 1,500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, Basel, SwitzerlandUpdated: Jul 24, 2025Locations: 1Duration: 10 Years
Eligibility criteria

At least 18 years of age [+6]

Individuals with CKM syndrome stage 4 according to the AHA [+7]

Read more